Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 29, 2015
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Eichhorst, T Robak, E Montserrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 5, 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia
B Eichhorst, P Ghia, C U Niemann, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 17, 2008
[Hematology 2008]
P Borchmann, B Eichhorst, M Hellmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2020
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Eichhorst, T Robak, E Montserrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2016
Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force
R Stauder, B Eichhorst, M E Hamaker, et al.
Leukemia
|
April 9, 2004
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
C-M Wendtner, M Ritgen, C D Schweighofer, et al.
Leukemia
|
February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
S Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia
|
October 16, 2019
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia
M Fürstenau, J Bahlo, A M Fink, et al.
Leukemia
|
May 3, 2016
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL
C Maurer, P Langerbeins, J Bahlo, et al.
Leukemia
|
March 24, 2020
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
O Al-Sawaf, S Robrecht, J Bahlo, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 29, 2015
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Eichhorst, T Robak, E Montserrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 5, 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia
B Eichhorst, P Ghia, C U Niemann, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 17, 2008
[Hematology 2008]
P Borchmann, B Eichhorst, M Hellmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2020
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Eichhorst, T Robak, E Montserrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2016
Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force
R Stauder, B Eichhorst, M E Hamaker, et al.
Leukemia
|
April 9, 2004
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
C-M Wendtner, M Ritgen, C D Schweighofer, et al.
Leukemia
|
February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
S Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia
|
October 16, 2019
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia
M Fürstenau, J Bahlo, A M Fink, et al.
Leukemia
|
May 3, 2016
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL
C Maurer, P Langerbeins, J Bahlo, et al.
Leukemia
|
March 24, 2020
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
O Al-Sawaf, S Robrecht, J Bahlo, et al.
Page
of 3